tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniel Busby, 1 are a HOLD (16.67%), 5 are a BUY (83.33%).
Analyst Daniel Busby, carries an average stock price target met ratio of 62.5% that have a potential upside of 30.67% achieved within 357 days.
Daniel Busby’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 10-Aug-2023.
Analyst best performing recommendations are on VRCA (VERRICA PHARMACEUTICALS).
The best stock recommendation documented was for VRCA (VERRICA PHARMACEUTICALS) at 7/25/2023. The price target of $14 was fulfilled within 434 days with a profit of $39.2 (73.68%) receiving and performance score of 1.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
7 months ago
(14-May-2025)
5/5 (100%)
$-2.5 (-17.24%)
363
Hold
8 months 6 days ago
(08-Apr-2025)
8/8 (100%)
$-42.5 (-76.58%)
621
Buy
$3
$-6.1 (-67.03%)
11 months 8 days ago
(06-Jan-2025)
0/1 (0%)
$-3.74 (-55.49%)
Hold
$2
$-7.1 (-78.02%)
$11
1 years 1 months 9 days ago
(05-Nov-2024)
4/5 (80%)
$-5.98 (-74.94%)
344
Hold
$20
1 years 2 months 12 days ago
(02-Oct-2024)
1/1 (100%)
$-59.6 (-74.87%)
78
What Year was the first public recommendation made by Daniel Busby?
